Biotia

Sepsis, an infection of the bloodstream, is an often deadly condition caused by a wide range of pathogens. An estimated 25-30% of sepsis cases are caused by an infection in the urinary tract. Treatment relies heavily on intravenous antibiotics and every hour that treatment is delayed increases a patient's risk of death. This , Biotia is turning awareness into action – with faster, more precise UTI diagnostics.

The BIOTIA-ID Urine Test, our first diagnostic offering, uses next-generation sequencing technology to detect all pathogen DNA in a patient’s urine sample. When the cause of sepsis is unknown, this test provides timely pathogen identification and information on antibiotic resistance, ensuring septic patients receive appropriate care. Stop guessing. Start testing.

We are proud to share that our new “test to treat” initiative for urinary tract infections, powered by the BIOTIA-ID Urine Test, is now available for patients across the United States. Biotia has created the first end-to-end model for advanced UTI testing and treatment through partnership with Clinova.Solutions, who provides patients with virtual care from experts in UTI patient management.

Patients experiencing recurrent, complicated, or culture-negative urinary tract infections may now purchase the at-home BIOTIA-ID Urine Test collection kit, collect a urine sample at home, and send it to the Biotia Laboratory for advanced diagnostic testing. They will have the opportunity to schedule a telehealth appointment to discuss their symptoms, their test results, and treatment options.

Know what you have. Treat what you know.